Compounds derived from cianopirazoles, modulators of the activity of GPR119 G Protein coupled receptor； Pharmaceutical Composition and Method for treating a disease, condition,Selected or Metabolic disorder of hyperlipidemia, diabetes type I, Type II diabetes mellitus, idiopathic Type 1 diabetes, among others.
MASCITTI, VINCENT,MCCLURE, KIM FRANCIS,MUNCHHOF, MICHAEL JOHN,ROBINSON, RALPH PELTON JR.
申请号：
CL2013001054
公开号：
CL2013001054A1
申请日:
2013.04.16
申请国别(地区):
CL
年份:
2013
代理人:
摘要：
Compounds that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein- coupled receptor GPR119 in animals are described herein.COMPUESTOS DERIVADOS DE CIANOPIRAZOLES, MODULADORES DE LA ACTIVIDAD DEL RECEPTOR GPR119 ACOPLADO A LA PROTEINA G； COMPOSICION FARMACEUTICA； Y METODO PARA TRATAR UNA ENFERMEDAD, AFECCION, O TRASTORNO METABOLICO SELECCIONADO DE HIPERLIPIDEMIA, DIABETES TIPO I, DIABETES MELLITUS TIPO II, DIABETES TIPO I IDIOPATICA, ENTRE OTRAS.
